Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Standards & Regulation

Business & Regulation Standards & Regulation

Biosimilar Boost

| Stephanie Sutton

AAM calls for policies in the US that encourage greater use of biosimilars.

Business & Regulation COVID-19

Fighting Fake COVID-19 Treatments

| Stephanie Sutton

Fake COVID-19 treatments and vaccines are abound – but the FDA is on the case.

Discovery & Development Drug Discovery

Exploring the Bounties of the Brain

| Maryam Mahdi

What progress is being made in the development of novel drugs in neuroscience?

Business & Regulation Vaccines

Fake Sputnik V Vaccines Seized

Mexico’s Customs and Armed Forces have seized a fake batch of the Sputnik V COVID-19 vaccine.

Business & Regulation Standards & Regulation

A Roadmap for Access

| Craig Burton

Craig Burton from the AAM says patients must be able to access generics and biosimilars.

Discovery & Development Drug Discovery

On the Cusp of Change

| Maryam Mahdi

Is pharma now ushering in a new era of precision in neuroscience R&D?

Business & Regulation Standards & Regulation

An Inspector Calls?

| Stephanie Sutton

How can the FDA tackle the inspection backlog?

Business & Regulation Vaccines

V for Victory?

| Stephanie Sutton

Sputnik V (finally and definitely) starts rolling review with the EMA.

Business & Regulation Business Practice

What’s Fueling Your Research Engine?

| Katrina A. Bramstedt

How to add value and reduce risks with ethics.

Discovery & Development COVID-19

Selfishness and Stupidity?

| Stephanie Sutton

We have vaccines. Now, pharma’s mission is to address novel variants. And vaccine hesitancy.

Latest White Papers

Overcoming the challenges of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

HRAM LC-MS method for the determination of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

LC-MS/MS method for the quantification of 10 nitrosamine impurities in metformin

| Contributed by Thermo Fisher Scientific

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine